Does SARS-CoV-2 Threaten Male Fertility?

Adv Exp Med Biol. 2021:1321:139-146. doi: 10.1007/978-3-030-59261-5_12.

Abstract

In the continuing COVID-19 pandemic, one of the most important concerns in reproductive health is the issue of male fertility of recovered patients. In this study, we discuss the potential mechanisms that justify the possible impact of COVID-19 on male fertility. The main point of entry of SARS-CoV-2 into the host cells appears to be through the viral spike protein which permits entry into cells via the angiotensin-converting enzyme 2 (ACE2 receptor). In human testes, ACE2 is enriched in Sertoli and Leydig cells and spermatogonia. Also, it seems that there is a mild or severe cytokine storm in patients with severe COVID-19, and such changes may affect fertility. It should also be mentioned that the orchitis caused by the SARS-CoV-2 virus may have an important impact on fertility. Prolonged and high fever may lead to changes in testicular temperature and destroy germ cells. In general, there is little evidence for a definite conclusion, but there are facts that suggest that COVID-19 may affect male fertility. It is prudent for men of reproductive age who have recovered from COVID-19 to be evaluated for the presence of the virus in semen and fertility-related items. There is an urgent need to conduct quality studies on, in particular, the long-term effects of COVID-19 on the fertility of recovered males.

Keywords: ACE2; Angiotensin-converting enzyme 2; Male fertility; SARS-Cov-2; Testis.

MeSH terms

  • COVID-19*
  • Fertility
  • Humans
  • Male
  • Pandemics*
  • Peptidyl-Dipeptidase A
  • SARS-CoV-2
  • Testis

Substances

  • Peptidyl-Dipeptidase A